分组1 - Wall Street anticipates a year-over-year decline in earnings for BrightSpire (BRSP) due to lower revenues, with earnings expected to be $0.16 per share, reflecting an 11.1% decrease, and revenues projected at $16.85 million, down 3.5% from the previous year [1][3] - The earnings report is scheduled for February 17, and if the actual results exceed expectations, the stock may rise; conversely, missing estimates could lead to a decline [2] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating that analysts have not reassessed their initial estimates during this period [4] 分组2 - The Zacks Earnings ESP model compares the Most Accurate Estimate to the Zacks Consensus Estimate, suggesting that recent revisions by analysts may provide more accurate predictions for earnings [8] - A positive Earnings ESP reading is a strong indicator of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3, with research showing a nearly 70% success rate for this combination [10] - The historical performance of Colony Credit shows that it has only beaten consensus EPS estimates once in the last four quarters, indicating a challenging outlook for future earnings surprises [14]

Core Viewpoint - Allegion (ALLE) is anticipated to report a year-over-year increase in earnings driven by higher revenues in its upcoming earnings report for the quarter ended December 2025, with the consensus outlook suggesting a positive earnings picture [1][3]. Earnings Expectations - The consensus estimate for Allegion's quarterly earnings is $2.01 per share, reflecting an 8.1% increase year-over-year, while revenues are projected to reach $1.03 billion, marking an 8.9% rise from the previous year [3]. - The stock may experience upward movement if the actual earnings exceed these expectations, whereas a miss could lead to a decline in stock price [2]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 3.18%, indicating a reassessment by analysts regarding the company's earnings prospects [4]. - The Most Accurate Estimate for Allegion is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +0.21%, suggesting a bullish outlook from analysts [12]. Earnings Surprise History - Allegion has a history of beating consensus EPS estimates, having surpassed expectations in the last four quarters, including a +4.07% surprise in the most recent quarter [13][14]. Predictive Indicators - A positive Earnings ESP is a strong indicator of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold), which enhances the predictive power of the Earnings ESP [10]. - Allegion currently holds a Zacks Rank of 3, indicating a likelihood of beating the consensus EPS estimate [12].

分组1 - CTS reported quarterly earnings of $0.62 per share, exceeding the Zacks Consensus Estimate of $0.60 per share, and up from $0.53 per share a year ago, representing an earnings surprise of +3.33% [1] - The company posted revenues of $137.27 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.04%, compared to year-ago revenues of $127.43 million [2] - CTS shares have increased approximately 29.7% since the beginning of the year, significantly outperforming the S&P 500's gain of 1.7% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.52 on revenues of $136.83 million, and for the current fiscal year, it is $2.40 on revenues of $561.5 million [7] - The Zacks Industry Rank for Electronics - Miscellaneous Components is in the top 16% of over 250 Zacks industries, indicating strong performance potential [8]

Company Performance - Plexus (PLXS) has seen a significant increase in its stock price, rising 29.9% over the past month and reaching a new 52-week high of $211.84 [1] - Year-to-date, Plexus has gained 41.7%, outperforming the Zacks Computer and Technology sector's 0.7% gain and the Zacks Electronics - Manufacturing Services industry's 12.5% return [1] Earnings and Revenue Expectations - Plexus has a strong track record of positive earnings surprises, having met or exceeded earnings consensus estimates in the last four quarters [2] - For the current fiscal year, Plexus is expected to report earnings of $7.61 per share on revenues of $4.45 billion, reflecting a 2.42% increase in EPS and a 10.46% increase in revenues [3] - For the next fiscal year, earnings are projected to rise to $8.45 per share on revenues of $4.81 billion, indicating year-over-year changes of 11.04% and 7.94%, respectively [3] Valuation Metrics - Plexus currently trades at 27.4 times the current fiscal year EPS estimates, which is above the peer industry average of 25.2 times [6] - On a trailing cash flow basis, Plexus trades at 22.1 times, compared to the peer group's average of 20 times [6] - The stock has a Value Score of B, a Growth Score of C, and a Momentum Score of A, resulting in a combined VGM Score of B [6] Zacks Rank - Plexus holds a Zacks Rank of 2 (Buy), supported by a solid earnings estimate revision trend [7] - The recommendation is for investors to consider stocks with a Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, indicating potential for Plexus shares in the near future [7] Industry Comparison - The Electronics - Manufacturing Services industry is performing well, ranking in the top 2% of all industries, providing favorable conditions for both Plexus and its peer, Jabil, Inc. (JBL) [10] - Jabil, Inc. also has a Zacks Rank of 2 (Buy) and has shown strong earnings performance, beating consensus estimates by 4.78% last quarter [9]

Company Overview - Carvana Co. (CVNA) has a market capitalization of $89.5 billion and operates an online platform for buying and selling used cars, providing services such as vehicle acquisition, inspection, reconditioning, financing, logistics, and post-sale customer support [1] Stock Performance - Over the past 52 weeks, CVNA shares have increased by 53.8%, outperforming the S&P 500 Index, which rose by 15.6%. However, on a year-to-date basis, CVNA shares are down 2.4%, while the S&P 500 has increased by 1.7% [2] - CVNA has also outperformed the State Street Consumer Discretionary Select Sector SPDR ETF (XLY), which rose by 4.1% over the same period [3] Financial Performance - In Q3 2025, Carvana reported revenue of $5.65 billion, exceeding expectations. However, shares fell by 13.8% the following day due to disappointing earnings, with profit of $1.03 per share missing Wall Street estimates and adjusted EBITDA margin declining to 11.3% [4] - Management's forward guidance projected Q4 retail unit sales just above 150,000, indicating a potential 4% quarter-on-quarter decline and a slowdown in year-on-year growth, despite a strong 44% increase in Q3 to 155,941 units [4] Earnings Expectations - For the fiscal year ending December 2025, analysts anticipate CVNA's EPS to rise by 389.2% year-over-year to $4.99. The company's earnings surprise history is mixed, with three out of the last four quarters beating consensus estimates [5] - Among 23 analysts covering the stock, the consensus rating is a "Strong Buy," consisting of 15 "Strong Buy" ratings, three "Moderate Buys," and five "Holds" [5] Analyst Ratings and Price Targets - The current analyst configuration is more bullish than three months ago, with 12 "Strong Buy" ratings. UBS analyst Joseph Spak maintained a "Buy" rating and set a price target of $545 [6] - The mean price target of $491.86 suggests a premium of 19.6% to CVNA's current levels, while the highest price target of $600 implies a potential upside of 45.9% from current prices [6]

Core Insights - XPLR Infrastructure (XIFR) reported quarterly earnings of $0.3 per share, significantly beating the Zacks Consensus Estimate of a loss of $0.78 per share, although this is a decrease from earnings of $0.99 per share a year ago [1] - The earnings surprise of +138.46% contrasts with a previous quarter where the company had a loss of $0.37 per share against an expectation of a loss of $0.07 per share, resulting in a surprise of -428.57% [2] - The company posted revenues of $249 million for the quarter, missing the Zacks Consensus Estimate by 7.87% and down from $294 million year-over-year [3] Financial Performance - The earnings surprise indicates a strong performance relative to expectations, with the company surpassing consensus EPS estimates three times over the last four quarters [2] - Despite the earnings beat, the revenue figures have consistently missed consensus estimates over the last four quarters [3] Market Position - XPLR Infrastructure shares have increased by approximately 1.8% since the beginning of the year, slightly outperforming the S&P 500's gain of 1.7% [4] - The current Zacks Rank for XPLR Infrastructure is 3 (Hold), suggesting that the stock is expected to perform in line with the market in the near future [7] Future Outlook - The consensus EPS estimate for the upcoming quarter is -$0.88 on revenues of $261.82 million, and for the current fiscal year, it is -$0.02 on revenues of $1.13 billion [8] - The outlook for the industry, particularly the Alternative Energy - Other sector, is currently in the bottom 36% of Zacks industries, which may impact stock performance [9] Industry Context - Another company in the same industry, Clearway Energy (CWEN), is expected to report a quarterly loss of $0.21 per share, reflecting a significant year-over-year change of -800%, with revenues projected at $304.76 million, up 19.1% from the previous year [10][11]

Core Insights - Edgewell Personal Care Company reported a Q1 fiscal 2026 GAAP EPS of -$1.41, impacted by the divestiture of its Feminine Care business, while adjusted EPS from continuing operations was -$0.16, outperforming the Zacks Consensus Estimate of -$0.18, resulting in an earnings surprise of 11.11% [1] - Revenue for the period was $422.8 million on a continuing operations basis, a 1.9% year-over-year increase, but below the Zacks Consensus Estimate of approximately $481.3 million, representing a 12.15% miss [2] - The company completed the divestiture of its Feminine Care business to Essity for $340 million, which is seen as a strategic move to focus on core areas and strengthen its balance sheet [3] Financial Performance - On a consolidated basis, net sales were $486.8 million, reflecting a 1.8% increase from the prior year, while organic net sales decreased by 0.5% on a continuing operations basis [2] - The company has exceeded consensus revenue estimates only once in the past four quarters, indicating ongoing challenges in meeting market expectations [2] - Financial ratios post-divestiture show a negative trailing P/E ratio of approximately -23.96, a P/S ratio of 0.42, a debt-to-equity ratio of 1.05, and a current ratio of 2.12, suggesting solid short-term financial health [5] Strategic Developments - The divestiture of the Feminine Care business is viewed as a pivotal milestone in the company's transformation, positioning Edgewell as a more focused and agile organization [3] - The company operates in a competitive consumer products industry, facing rivals such as Procter & Gamble and Unilever, and its Q1 performance modestly exceeded internal expectations for organic net sales, adjusted EPS, and adjusted EBITDA [4]

Core Viewpoint - Smurfit Westrock PLC (SW) is expected to report fourth-quarter 2025 results on February 11, with revenues projected at $7.67 billion, reflecting a 1.7% year-over-year growth, and earnings per share (EPS) estimated at 46 cents, up from 34 cents in the previous year [1][5]. Financial Estimates - The Zacks Consensus Estimate for revenues is $7.67 billion, indicating a 1.7% increase from the same quarter last year [1][5]. - The EPS consensus is set at 46 cents, showing a rise from 34 cents year-over-year [1][5]. - The earnings surprise history shows that the company has beaten the Zacks Consensus Estimate once in the last four quarters, with an average negative surprise of 18.4% [2]. Segment Performance - The Europe, MEA, and APAC segment is projected to generate revenues of $2.74 billion, up from $2.51 billion in the fourth quarter of 2024, with adjusted EBITDA estimated at $426 million, an increase from $371 million [7]. - North America's revenue estimate for Q4 2025 is $4.49 billion, slightly down from $4.52 billion reported in the previous year, with adjusted EBITDA expected to be $716 million, indicating a 0.8% year-over-year growth [8]. - The LATAM segment's revenue is estimated at $533 million, up from $505 million, but adjusted EBITDA is projected to decline to $116 million from $121 million in the prior-year quarter [9]. Market Trends and Challenges - Demand for corrugated packaging and containerboard remains stable, driven by e-commerce growth and the need for sustainable packaging solutions [3]. - However, weak volumes in Europe and lower box demand are anticipated to negatively impact quarterly results [4][5]. - Merger-related costs are expected to affect performance and free cash flow margin, although pricing actions and cost-saving initiatives may mitigate some of these challenges [6]. Stock Performance - Smurfit Westrock's stock has declined by 14.2% over the past year, compared to a 6.1% decline in the industry [11].

Core Viewpoint - West Pharmaceutical Services (WST) is expected to report fourth-quarter 2025 results on February 12, with a history of earnings surprises, averaging 15.52% over the last four quarters [2][3]. Q4 Estimates - The company anticipates fourth-quarter revenues between $790 million and $800 million, indicating organic sales growth of 1% to 2.3%. Adjusted diluted earnings per share (EPS) are projected to be between $1.81 and $1.86 [3][10]. - The Zacks Consensus Estimate for revenues stands at $794.3 million, reflecting a year-over-year growth of 6.1%, while the consensus for earnings is $1.83 per share, showing a 0.6% improvement [3]. Revenue Breakdown - Total revenues are estimated at $792.7 million, suggesting a 2.5% organic improvement year over year. The Proprietary Products segment is expected to generate $645.3 million (1.9% organic growth), while Contract-Manufactured Products are projected at $147.4 million [4]. - Operating profit for the Proprietary Products segment is likely to increase by 2.2%, whereas the Contract-Manufactured Products segment is expected to decline by 13.9% [4]. Factors Influencing Sales - Sales growth in Q4 is anticipated to be driven by strong demand for West Pharmaceutical's high-value product (HVP) portfolio, which has a higher margin that may positively impact gross margin [5]. - The company raised its growth estimate for the HVP portfolio by 50 basis points, indicating ongoing strength despite a projected unfavorable tariff impact of $15 million to $20 million for the full year [5]. Segment Performance - The Proprietary Products segment includes HVP Components, HVP Delivery Devices, and Standard Products, serving various medical companies [6]. - The HVP Components business accounted for 48% of total sales in Q3 2025, with organic growth of 13.3% year over year, driven by demand for GLP-1s and biologics [7]. - Despite manufacturing constraints in Germany, similar growth trends are expected to continue in Q4, although a $25 million incentive from the previous quarter may not recur, potentially affecting sales [8]. Cost Management and Product Transition - Growth in laminated technology products and strong performance in Westar and Envision are expected to partially offset the absence of the prior incentive [9]. - The Standard Products business is likely to maintain moderate growth, aided by HVP upgrades due to new regulations in Europe [9][11]. Contract Manufacturing Segment - The Contract Manufacturing segment is expected to benefit from ongoing demand for self-injected devices for obesity and diabetes, with potential pricing improvements [12]. However, lower demand for healthcare diagnostic devices may partially counterbalance these gains [12].

Company Overview - Valero Energy Corporation (VLO) has a market cap of $61.8 billion and operates in the production and marketing of petroleum-based and low-carbon transportation fuels and petrochemical products through its Refining, Renewable Diesel, and Ethanol segments [1] Stock Performance - Over the past 52 weeks, VLO stock has increased by 51.7%, significantly outperforming the S&P 500 Index, which rose by 14.9% during the same period [2] - Year-to-date, VLO shares are up nearly 24%, compared to a modest 1.1% gain for the S&P 500 [2] - VLO has also outperformed the State Street Energy Select Sector SPDR ETF (XLE), which saw a 20.2% increase over the past year [3] Financial Performance - In Q4 2025, Valero reported an adjusted EPS of $3.82 and revenue of $30.37 billion, exceeding expectations; however, shares fell slightly due to concerns over declining full-year profitability, with net income expected to decrease to $2.3 billion ($7.57 per share) from $2.8 billion ($8.58 per share) in 2024 [6] - Operating income in the Renewable Diesel segment fell to $92 million from $170 million year-over-year, contributing to investor caution [6] Future Projections - Analysts forecast a 15.8% year-over-year growth in adjusted EPS for the fiscal year ending December 2026, projecting it to reach $12.29 [7] - Valero has a strong earnings surprise history, having beaten consensus estimates in the last four quarters [7] Analyst Ratings - Among 22 analysts covering Valero, the consensus rating is a "Moderate Buy," consisting of 12 "Strong Buy" ratings, one "Moderate Buy," and nine "Holds" [7] - Citi analyst Vikram Bagri raised Valero's price target to $212 while maintaining a "Neutral" rating, with the stock currently trading above the mean price target of $193.95 [8] - The highest price target of $220 suggests a potential upside of 8.6% from current levels [8]